Amaero International Limited (ASX: $3DA) has announced its March 2024 Quarterly Activities Report, highlighting significant achievements including a binding offtake agreement for C103 AM powder and the completion of a A$20 million institutional placement. The company is positioning itself as the largest U.S. domestic producer of C103 and specialty alloy AM powders.
Following bold and decisive corporate actions over the past year, the March 2024 quarter was a key period for the Company, as we have continued to execute on our strategy and advance important milestones to position Amaero as the largest U.S. domestic producer of C103 and specialty alloy AM powders. We are presented with a strong generational re-shoring opportunity, to bring highly strategic industrial base capabilities back to the U.S., and to contribute to a more resilient and scalable supply chain for defense production and for the space economy.
Amaero International has made significant progress in securing a binding offtake agreement for C103 AM powder with a leading additive manufacturer, as well as completing a A$20 million institutional placement. The company's strategic positioning aims to capitalize on the re-shoring opportunity and the growing demand for metal 3D printing in defense and space industries. With the commencement of the first atomiser installation and the appointment of Guggenheim Securities to explore equity financing alternatives, Amaero is focused on achieving near-term milestones and aims to fully fund its capital expenditure and working capital needs. The company's ambitions include becoming the largest and preferred supplier of C103 and specialty alloy AM powders in the United States, with an outlook for positive net income from operations expected in FY2026.